# GoodRx

> GoodRx is a Santa Monica-based digital healthcare platform that helps Americans find lower prices on prescription drugs. It aggregates real-time pricing and discounts from pharmacies nationwide so consumers can compare costs and access free coupons, then layers on telehealth visits, manufacturer savings programs, and tools for pharma and employers. Since 2011 it has helped tens of millions of people save an estimated $70+ billion on medications.

- **Founded:** 2011
- **Headquarters:** Santa Monica, California, United States
- **Founders:** Doug Hirsch (Co-Founder & former Co-CEO (ex-Facebook, ex-Yahoo!)), Trevor Bezdek (Co-Founder & former Co-CEO), Scott Marlette (Co-Founder (ex-Facebook))
- **Team size:** ~700-1,000 employees
- **Products:** GoodRx Prescription Discounts, GoodRx Gold / Companion, GoodRx Care (Telehealth), Pharma Manufacturer Solutions (Pharma Direct), GoodRx Employer Direct
- **Notable:** Helped consumers save an estimated $70+ billion on prescriptions, Reached ~30 million unique users, IPO'd on Nasdaq in 2020 at ~$12.7B valuation, raising $1.1B

## Products & services

- **GoodRx Prescription Discounts** — Free price-comparison tool and coupons that show real-time discounted drug prices across U.S. pharmacies.
- **GoodRx Gold / Companion** — Subscription memberships bundling low-cost generics, $19 telehealth visits, and savings on dental, vision, lab and imaging services.
- **GoodRx Care (Telehealth)** — Online doctor visits and prescriptions for common conditions.
- **Pharma Manufacturer Solutions (Pharma Direct)** — Affordability and patient-access programs that connect drugmakers' brand savings, including GLP-1s, to patients.
- **GoodRx Employer Direct** — Employer-funded subsidies to lower out-of-pocket costs for high-impact brand medications.
- **GoodRx Health** — Editorial library of consumer health and medication information.

## Achievements

- Helped consumers save an estimated $70+ billion on prescriptions
- Reached ~30 million unique users
- IPO'd on Nasdaq in 2020 at ~$12.7B valuation, raising $1.1B
- FY2025 revenue of $796.9M with ~33.9% adjusted EBITDA margin

## Latest updates

- **2026-05** — Launched GoodRx Companion, a $14.99/month subscription bundling low-cost generics, $19 telehealth visits, and dental/vision/lab/imaging savings.
- **2026-02** — Launched GoodRx Employer Direct, offering employers subsidies for high-impact brand medications including GLP-1s.
- **2026** — Expanded GLP-1 access: Wegovy HD self-pay at $399/month, plus Eli Lilly's oral GLP-1 Foundayo and Zepbound KwikPen.
- **2026-Q1** — Reported Q1 2026 revenue of $194.0M with adjusted EBITDA of $58.3M (30% margin); Pharma Direct revenue up 41% to $151M.

## Links

- Website: https://www.goodrx.com
- LinkedIn: http://www.linkedin.com/company/goodrx
- Twitter/X: https://twitter.com/goodrx
- YouTube: https://www.youtube.com/goodrx
- Instagram: https://www.instagram.com/goodrx
- Facebook: https://www.facebook.com/goodrx
- TikTok: https://www.tiktok.com/@goodrx

---

Profile page: https://yespress.io/goodrx
Published by YesPress — https://yespress.io
Last updated: 2026-06-02